Shaw AT, Friboulet L, Leshchiner I, et al. Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F. N Engl J Med. 2016;374(1):54-61. doi:10.1056/NEJMoa1508887
Jenni S, Goyal Y, von Grotthuss M, Shvartsman SY, Klein DE. Structural Basis of Neurohormone Perception by the Receptor Tyrosine Kinase Torso. Mol Cell. 2015;60(6):941-52. doi:10.1016/j.molcel.2015.10.026
Sapkota BR, Hopkins R, Bjonnes A, et al. Genome-wide association study of 25(OH) Vitamin D concentrations in Punjabi Sikhs: Results of the Asian Indian diabetic heart study. J Steroid Biochem Mol Biol. 2016;158:149-56. doi:10.1016/j.jsbmb.2015.12.014
Salihovic S, Ganna A, Fall T, et al. The metabolic fingerprint of p,p’-DDE and HCB exposure in humans. Environ Int. 2016;88:60-6. doi:10.1016/j.envint.2015.12.015
Hoofnagle AN, Whiteaker JR, Carr SA, et al. Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays. Clin Chem. 2016;62(1):48-69. doi:10.1373/clinchem.2015.250563
Ghaoui R, Palmio J, Brewer J, et al. Mutations in HSPB8 causing a new phenotype of distal myopathy and motor neuropathy. Neurology. 2016;86(4):391-8. doi:10.1212/WNL.0000000000002324
Cancer Cell Line Encyclopedia Consortium, Genomics of Drug Sensitivity in Cancer Consortium. Pharmacogenomic agreement between two cancer cell line data sets. Nature. 2015;528(7580):84-7. doi:10.1038/nature15736
Farese RV, Walther TC. Lipid droplets go nuclear. J Cell Biol. 2016;212(1):7-8. doi:10.1083/jcb.201512056
Tibbitt MW, Dahlman JE, Langer R. Emerging Frontiers in Drug Delivery. J Am Chem Soc. 2016;138(3):704-17. doi:10.1021/jacs.5b09974
Richards AL, Leonenko G, Walters JT, et al. Exome arrays capture polygenic rare variant contributions to schizophrenia. Hum Mol Genet. 2016;25(5):1001-7. doi:10.1093/hmg/ddv620